Vertigo
96
10
14
53
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Research Maturity
53 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.2%
4 terminated out of 96 trials
93.0%
+6.4% vs benchmark
9%
9 trials in Phase 3/4
11%
6 of 53 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 53 completed trials
Clinical Trials (96)
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease
Videonystagmography and Vestibular Migraine
China Dizziness and Vertigo Cohort Study （VERIDICAL STUDY）
Evaluation of Nystagmus Examination Using Wearable AR Glasses in Vertigo Patients
Diagnostic Work up and Management of Acute Onset Vertigo
Effects of Wiifit vs Conventional Vestibular Rehabilitation on Dizziness and Balance in Patients With Unilateral Peripheral Vestibular Dysfunction
Multimodal Physiotherapy for Balance and Vertigo in BPPV Patients
Implementation of Evidence-Based Practice for Dizziness
Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes
Prospective Registry of Vertigo Due to Vertebrobasilar Transient Attacks.
Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT)
Diagnostic Aid for Vertigo Patients
Gastrodin Acupoint Injection for Sensorineural Hearing Loss With Vertigo
Reducing Vertigo Associated With MRI Machines
Chinese Real-world Study of Treatment of Vestibular Migraine
Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting
Validation of a Simultaneous Ocular/Cervical VEMP With Mastoid Vibration by B250
Clinical Trial of Vit D and Calcium for Recurrent BPPV
Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo